bpc-157 multiple sclerosis study Pentadecapeptide BPC 157 resolves Pringle maneuver in rats, both ischemia and reperfusion Body Protecting Compound 157 (BPC-157

Its uses range from treating peripheral neuropathy and vitamin B12 deficiency to managing complex neuralgias, offering patients rapid relief and long-term nerve support

Common side effects may include: Nausea Injection site reactions Fatigue Headache Digestive upset These side effects are usually mild and temporary

Unlike single-target supplements, its multimodal mechanism addresses multiple aspects of brain health simultaneously: neuroprotection, neurotrophic support, anti-neuroinflammation, and neuroplasticity

PMID 31340802

Entering a target dose of 1,000mcg (1.0mg) will show that 0.2mL, or 20 units on a U-100 syringe, is needed